|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 51/10 | |
| A61K 51/00 | |||
| A61K 39/395 | |||
| A61K 31/427 | |||
| A61K 31/7036 | |||
| C07K 16/28 | |||
| A61K 39/00 | |||
| A61M 5/14 | |||
| A61K 47/68 | |||
| A61P 35/02 | |||
| A61B 6/00 | |||
| A61K 9/00 | |||
| A61K 101/02 |
| (11) | Patento numeris | 3297684 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16797365.0 |
| Europos patento paraiškos padavimo data | 2016-05-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/033479 |
| Data | 2016-05-20 |
| (87) | Numeris | WO 2016/187514 |
| Data | 2016-11-24 |
| (30) | Numeris | Data | Šalis |
| 201562164601 P | 2015-05-21 | US |
| (72) |
DAVE, Kaushik, J., US
ZHANG, Yulian, US
|
| (73) |
Actinium Pharmaceuticals, Inc.,
275 Madison Avenue, 7th Floor, New York, NY 10016,
US
|
| (54) | INFUSION ADMINISTRATION OF CONJUGATED MONOCLONAL ANTIBODIES |
| INFUSION ADMINISTRATION OF CONJUGATED MONOCLONAL ANTIBODIES |